Skip to main content

Advertisement

Table 1 Clinical information

From: Involvement of DPP9 in gene fusions in serous ovarian carcinoma

Sample Patient Age Dx Stadium Karyotype: chr19 RNA-seq Neo chemo
1 I 66 HGSC IIIC No der(19)b   
2 II 47 HGSC IIIB der(19) V  
3 IIIa 54 HGSC IIIC No der(19)b   
4 IIIb 54 HGSC IIIC der(19) V  
5 IVa 61 HGSC IIIC Culture failureb   
6 IVb 61 HGSC IIIC der(19) V  
7 V 52 HGSC IIIC der(19) V  
8 VI 50 HGSC IV der(19) V  
9 VII 66 HGSC IV der(19) V  
10 VIII 59 HGSC IV der(19) V yes
11 IX 56 HGSC IIIC der(19) V  
12 X 51 UC IIC der(19) V  
13 XI 74 HGSC IIIC der(19) V yes
14 XII 57 HGSC IIIC 46,XXb   
15 XIIIa 64 HGSC IIC der(19) V  
16 XIIIb 64 HGSC IIC 46,XXb   
17 XIV 63 HGSC IIIC der(19) V  
18 XV 56 SCa IIIC der(19)   yes
19 XVI 77 HGSC IIIC der(19) V  
  1. Dx diagnosis, HGSC high-grade serous carcinoma, Neo chemo neoadjuvant chemotherapy, UC undifferentiated carcinoma
  2. aSC = serous carcinoma, cannot be graded due to chemo
  3. bbilateral tumor has der(19) in the karyotype